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We wish to present evidence that antibody-dependent cytolytic lymphoid cells
from human blood have receptors for activated C3 . Using target cells bearing
activated C3 no cytolysis was induced by these effector cells in the absence ofIgG
antibody . These results point to the importance of the interaction between the
cellular Fe receptor and the Fc part of the inducing antibody as the triggering
event for the antibody-dependent cytolytic reaction .
Purified lymphocytes from the blood of normal donors are cytolytic for various
target cells in the presence of antitarget cell antibodies . In a model system
consisting of "Cr-labeled chicken erythrocytes (E,)' and IgG anti-E, from
hyperimmune rabbits, we have previously shown that T cells have no effector
function in this system (1) . Similar findings have been reported for animal
models (2, 3) . It has also been reported that mature B cells with high
concentration of surface-bound immunoglobulin seem to be inactive in this
cytolytic system (4, 5) . It is not known ifthe effector cells are true lymphocytesor
are cells of lymphocytic appearance but belonging to a nonlymphocytic lineage .
The cytolytic reaction does not require participation of complement (C) factors
C5-C9 (6,.7) .
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andU. S. Public Health Service grant AI-07007 . This is publication no . 899 from the Scripps Clinic
and Research Foundation .
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'Abbreviations used in this paper:
￿
A, rabbit antibody to boiled sheep erythrocyte stromata, Igm
fraction ; a-E,, antiserum from rabbits, hyperimmunized to chicken erythrocytes ; C(hu), human
complement ; C(ra), rabbit complement ; C3b INA, Cab inactivator ; CRL, complement receptor
lymphocytes ; E,, chicken erythrocytes ; E ., sheep erythrocytes ; ER, lymphocytes forming rosettes
with Es; FCS, fetal calf serum ; HGG, human gamma globulin ; HSA, human serum albumin; NRS,
normal rabbit serum ; TH,Tris-buffered Hank's balanced salt solution ; VBS, veronal-buffered saline .
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Materials and Methods
Solutions .
￿
Tris-buffered Hank's balanced salt solution (TH) (pH7 .4) andveronal-buffered saline
(VBS) were prepared as described (8, 9) . VBS-Ca,Mg contained 0.15mM Ca2+ and0.54mM Mg2+ .
Tissue culture medium RPMI 1640 (Bio-Cult, Paisley, Scotland) was supplemented with 2 mM
glutamine, 100 IU penicillin, 100 jug streptomycin/ml and, when indicated, with HEPES-buffer .
Mixtures of Ficoll (Pharmacia Fine Chemicals, Inc ., Uppsala, Sweden) and Isopaque (Nyegaard,
Oslo, Norway) (sp gr 1.070-1.078) were prepared according to the method used by Boyum (10) .
Human serum albumin (HSA) (Kabi, Stockholm, Sweden) was used as 8% stock solution in TH .
Gelatin (EdibleCompoundsLtd., Stone Ferry, Hall, Yorkshire, England) was prepared as described
earlier (8) .
Sera . Antiserum from rabbits hyperimmunized to E, (a-E,) and normal rabbit serum (NRS)
were prepared as previously described (8) . TheIgM fraction of rabbit antiserum against boiled sheep
erythrocyte stromata (A) was obtained by gel exclusion chromatography through Sephadex G-200
(Pharmacia Fine Chemicals, Inc.) . Fetal calf serum (FCS) was from Flow Laboratories, Inc., Irvine
Scotland . All sera were heat inactivated at 56°C for 45 min .
Complement (C) .
￿
PurifiedHuman C Components . Cl (11), CIs (12), C4(13), C2 (14),and C3(15)
were prepared as described . Serumfrom C6-deficient rabbits (Rancho de Conejo, Vista, Calif.) served
as thesource ofrabbit C [C(ra) ] . When necessary, therabbit serum was freed from natural antibodies
to sheep erythrocytes (E.) or E, by absorption in the presence of 0.005M EDTA .
EC4°'y23(hu) .
￿
Intermediates of either E, or Ee were prepared by fluid-phase activation without
antibody (16) . 800kg active C4 and280 jug C1swere mixedand added to 8 ml 5%E (8 x 109 Ea or 3 x
10 9 E,), washed three times with VBS-Ca,Mg . After 15 min incubation at 37°C and two washes in
VBS, 500 kg C2°"' (17) were added. After 5 min at 37°C,280 kg Cls, and after additional 10 min 1.4
mg C3 were added.The cellswere furtherincubated for30 minat 37'C . They were then washed twice
in VBS-Ca,Mg and resuspended in 40 ml to give 1% suspensions . The activity of cell-bound C3b was
assessed by immune adherence (18) . The number of cell-bound C3 molecules was also measured
directly by building up intermediates with `261-labeled C3 .The sp act oftwodifferent preparations of
C3 were 30,000 and 50,000 cpm/kg, respectively .
EAC(ra) .
￿
To form EA, 1 ml 5%washedE inTH (109Ee or 3 .7 x 10 1E .) were incubated for30 min
at 37°C with 1 ml of A. This IgM fraction which reacted with both E a and E, was used at a
subagglutinating dilution inTH (1:200) . EAC(ra) were prepared by mixing 0.25 ml EA with 0.25 ml
C6-deficient rabbit serum, diluted 1 :4 (TH) . After 30 min at 37C, the cells were washed twice with 10
ml cold TH. For control, portions ofEA were mixed with heat-inactivated serum, or with TH only .
EAC(ra) were lysed when incubated with NRS in microtitration plates (end point for lysis
1:64-1:125) .
Isolation ofHumanLymphocytesfrom defibrinated bloodwasperformedby gelatinsedimentation,
iron uptake, and Ficoll isopaque centrifugation (1, 8, 19). To remove remainingmonocytic cells, the
suspensions were incubated in 10% FCS over night in Falcon tissue culture flasks (Falcon Plastics,
Div. of BioQuest, Oxnard, Calif.) . This procedure gives mononuclear cell suspensions consisting to
^-99% of viable lymphocytes .
Fractionation of Lymphocytes on EC4"y23(hu) columns .
￿
Acid-treated glass beads (superbrite
3M, type 100-500 ; 3M Co ., St . Paul, Minn .) were treated with an equal volume of poly-[.-lysine
(hydrobromide, lot ly-151, mol wt 25,000-50,000; Miles Laboratories, Inc., Miles Research Div.,
Kankakee, Ill.), 20 Ag/ml in sterile NaCl (20) . After incubation at 4°C overnight the beads were
washed once with saline andpoured into glass columns, 15 x 300 mm, 25- to 30-mlbeads/column. The
columns were charged with 10 ml of a 10% suspension ofE.C4°Iy23(hu), (10' 6E/column) andwashed
with saline until the eluates were free of cells . Control columns were charged with untreated E. . The
erythrocytes on the columns were lysed with 20 ml of distilled water and washed with saline until
completely free of hemoglobin . 10 ml of 2% Ea were added at this stage and passaged through the
column with ^-20 ml saline . Saturation was reflected by passage of the erythrocytes as a narrow red
band . The column was filled with RPMI 1640 containing 0.4% HSA, immediately followed by
addition of lymphocytes (-20 x 10 6 lymphocytes/column) which were passaged through the column
at a rate of 2-3 ml/min with 40-50 ml HSA-containing medium .
Receptor Lymphocytes (CRL) (21) .
￿
The fraction of lymphocytes forming rosettes with E,AC(ra)
or E,C4°"23(hu) was determined according to the method used by Jondal et al . (22) . 0.25 ml ofP . PERLMANN, H . PERLMANN, AND H . J . MOLLER-EBERHARD
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lymphocytes (1 x 10°) in HEPES-RPMI were incubated with 0.25 ml of 0 .5% suspensions of the
C-treated erythrocytes (2 .5 x 10') . Lymphocytes binding four or more erythrocytes were scored as
CRL .
CRL Depletion .
￿
Rosettes formed by lymphocyte-E.AC(ra) mixtures and control mixtures were
suspended in 5 ml 8% HSAplus 1.7 ml 3% gelatin in TH, and centrifuged forafew minutes at -350 g .
The supernate containing lymphocytes depleted of CRL was withdrawn .
Rosette Formation with E, (ER) .
￿
The fraction of lymphocytes formingspontaneous rosettes with
E, in concentratedFCS wasdetermined according to the methods used by Jondal et al . (22) andYata
et al . (23) .
ER Depletion . 0.5 ml lymphocytes (8 x 10') and 0.5 ml Ea (1 x 10 8) in FCS were mixed and
incubated in the refrigerator overnight . 2 ml ficoll-isopaque were layered under 2 ml cell suspension
(- 15 x 10 8 lymphocytes and2 x 10 8 E./tube) and the mixtures were centrifuged for 40 min at 800g at
room temperature. The ER-depleted lymphocytes were recovered from the interphase .
Lymphocyte-Mediated Cytolysis of Erythrocytes . E,, or in a few experiments I,, either
untreated or treated with C, were labeled with Na,S'CrO, (0.5-1.0 mCi/ml ; 3-10 jug Cr/ml ; The
Radiochemical Center, Amersham, England) as described (1, 8, 19) . When C-treated erythrocytes
were used, FCS (2.5%) was substituted with HSA (0.2%) throughout the labeling procedure .
For the cytolysis experiments, all dilutions were made in RPMI 1640 containing 5% FCS or 0.4%
HSA . The number of target cells per incubation tube was 2 x 10'-8 x 10', while the number of
lymphocytes varied froni"2 x 10 5-8 x 105 .The final dilution ofa-E. or NRS was10-5 or 3 x 10-8 , total
vol of incubation mixture 0.3 ml . In some experiments, the total volwas 1.5 ml, with correspondingly
larger numbers of cells . If not otherwise indicated, lysis is given as percent of total isotope released
after 15-20 h from cells to medium, corrected by substracting percent spontaneous release in
lymphocyte-free control tubes . All tubes were set up in duplicate (SE < 2%) (1, 8, 19) .
Results
Experimental procedures . With optimal concentrations of antiserum (final
dilutions 10 -5-3 x 10-s ) and optimal lymphocyte to E, ratios (> 10:1) complete
lysis is usually seen after about 15-20 h of incubation . At this time, suboptimal
ratios, e .g . 5:1, give incomplete but fully significant lysis . 18 h of incubation and
different lymphocyte to E, ratios were therefore chosen to assay lymphocyte
activities (1, 19) .
Depletion of Antibody-Dependent Effector Cells by Human C3b Columns.
EBC4°"y23(hu) intermediates (7,000-10,000 C3 molecules/E") were adsorbed
to glass bead columns . Their retention on the column was assessed by C3-bound
radioactivity . In a typical experiment, the total amount C3b initially retained
was approximately 35 Ag . The total amount eluted during all subsequent
washings and lymphocyte passage was 17% . Almost 10% of the total came off
during elution with RPMI 1640 containing 5% FCS . Since FCS contained C3b
inactivator (C3b INA) which converts C3b to C3c and C3d (24) and thereby
abolished immune adherence activity of E,,C4°"Y23(hu), it was in all subsequent
experiments replaced by HSA . Under these conditions, C3b was not affected and
losses were kept to a minimum .
The yield of cells passaged through the E,,C4°"y23(hu) column and the ES
control column was -30% . However, while the loss of lymphocytes on the control
column was random, the EeC4°"y23(hu) column gave an eluate in which the
T-cell fraction was increased and the fraction of CRL was markedly decreased .
Table I shows the results of a typical experiment in which unfractionated and
column-passaged lymphocytes were tested for antibody-dependent cytolysis . In
order to increase the sensitivity of the system, effector cell to target cell ratios290
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TABLE I
SurfaceMarkersandAntibody-Dependent Cytolytic Potential of Lymphocytes Passaged
Through Glass Bead Column Charged withEe Membranes Bearing Human Cab
%"Crrelease (corrected)$
* E,C40xY23(hu) rosette-forming cells .
$ Means of duplicate incubations, ranges <2%. 0, release equal or less than in lymphocyte-free
controls (<2%). Lymphocyte/E,, 5:1 .
were kept at a suboptimal level (5:1) . All column-passaged samples had reduced
lytic activity . However, while reduction of cytolysis by the control lymphocytes
was slight (-20%), that of the E,,C40xY23(hu) column-passaged cells was sig-
nificantly stronger (-65%), corresponding to a -75% reduction in CRL.
Depletion ofAntibody-Dependent Effector Cells by Centrifugation ofESAC(ra)
rosette-forming cells (CRL) . Centrifugation methods to deplete mouse lympho-
cytes with receptors for mouse C have been described (21, 25) . The mean
percentage of CRL found here with the lymphocytes from 10 normal donors was
19.1 f 1 .2 (SE) . After centrifugation through HSA-gelatin, the fraction of CRL
recovered from the interphase was 2.4 t 1 .3 (SE) .
Table II shows that depletion of cells with receptor for C(ra) strongly reduced
cytolytic activity . As was to be expected (4), cell preparations depleted ofT cells
had a strong antibody-dependent cytolytic potential (exps . 5 and 6, Table II) .
C on Target Erythrocytes does not Trigger Lymphocyte-Mediated Cytolysis .
E,C4°"23(hu) (30,000 molecules C3b/erythrocyte) were employed as target
cells. They were strongly active in immune adherence . The results of a typical
cytolysis experiment in which the medium was supplemented with either 5% FCS
or 0.4% HSA are shown in Table IIl . E,C40xY23(hu) were not lysed in either case
in spite of the high lymphocyte to target cell ratio applied in this experiment .
This suggests that neither C3b nor C3d formed in the presence ofFCS, were able
to trigger a cytolytic response . When a-E, (IgG) at high dilution was added to the
lymphocyte/E, mixture, complete lysis was obtained with both media.
Purified lymphocytes were first passaged through columns charged with
human gamma globulin (HGG)/rabbit anti-HGG, previously shown to retain
antibody-dependent effector cells (1, 4) . Unfractionated and column-passaged
lymphocytes were incubated with three types of target cells (Table IV) . No
cytolysis was induced in the absence of anti-Ec in any case . However, in the
presence of anti-E,, cytolysis of EcC4°"23(hu) was significantly elevated over
that of Ec . This was particularly pronounced with effector cells passaged through
the HGG/anti-HGG column .
Lymphocytes ER CRL*
NRS a-E,
% 1 70
Untreated 43 19 1 17
Ea column passaged 36 18 0 13
E,C4°xy23(hu) column passaged 64 4 0 6P . PERLMANN, H . PERLMANN, AND H . J . MULLER-EBERHARD
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TABLE II
Cytolytic Potential of CRL- or ER-Depleted Lymphocytes
* E OAC(ra) rosette-forming cells .
$ Lymphocyte/E,, 10 :1 . 0, release equal or less than in lymphocyte-free controls (<2 .5%) .
TABLE III
Effect of Lymphocytes on E, Bearing Human Cab
Medium
% "Cr release (total)*
E,
￿
E~ + a-E.
￿
E,C4"y 23(hu)
RPMI 1640 + 0.4% HSA
￿
1
￿
94
￿
5
RPMI 1640 + 5% FCS
￿
2
￿
91
￿
3
*Total (uncorrected) release . Lymphocyte/E ., 40 :1 . Spontaneous release in lympho-
cyte-free controls, 9-12% .
In a second series of experiments E,AC(ra) or E.AC(ra) were used as target
cells . The IgM fraction of the anti-E, stroma antibody (A), employed for C
activation did not induce lymphocyte-mediated cytolysis. Table V presents the
results of six independent experiments, performed with the lymphocytes from six
different donors . No lysis was seen when E,AC(ra) or E,,AC(ra) were used as
target cells although they carried enough C for optimal rosette formation .
Addition of IgG anti-E, induced cell-mediated lysis in all cases .
Exp . Lymphocytes CRL*
"Cr release
NRS
(corrected)$
a-E,
1 Untreated 20 0 93
CRL depleted 2 .5 0 1
2 Untreated 17 0 72
CRL depleted 1 0 0
3 Untreated 23 1 16
CRL depleted 2 0 1
4 Untreated 26 0 55
CRL depleted 6 0 2
5 ER depleted 40 0 60
CRL depleted 1 0 2
6 ER depleted 49 0 54
CRL depleted 2 0 8292
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TABLE IV
Effect of Fractionated Lymphocytes on E, Bearing Human C4b or Cab
* E,C4°'y23(hu) rosette-forming cells .
$ Lymphocyte/E,, 12.5 :1 . RPMI 1640 + 0.4% HSA . NRS or a-E, final dilutions 10- s . 0, release equal
or less than in lymphocyte-free controls [E,, 1% ; E,C4(hu), 4% ; and E,C4°"23(hu), 12%] .
§ Glass beads treated with FCS or HGG/rabbit anti-HGG (1, 4, 20) .
Exp . CRL*
Effect of Lymphocytes on E, or ES Bearing IgM Antibody and C(ra)
Target
cells
TABLE V
Discussion
"Cr release (corrected)$
"Cr release (corrected)$
Lymphocyte/E EA
￿
EAC(ra)
* Lymphocytes forming rosettes with portions of E.AC(ra) used as target cells in exp . 4-6 .
$RPMI 1640 + 0.4% HSA .NRS or a-Ec final dilutions, 3 x 10 -8 . Release in lymphocyte-free controls :
exp. 1, 10-13% ; 2, 6-8% ; 3, 4-6% ; 4, 10-12% ; 5, 9-11% ; and 6, 12-17% .
Depletion of cells with C receptors was achieved by two independent methods
and with C of two different sources . Columns charged with membranes ofEeAC
(mouse) have recently been used by Jondal et al . (26) to remove CRL from
human blood. In our experiments, the glass beads were coated with cell
membranes bearing human C3b, produced by fluid-phase activation of C4
without application of antibody . This procedure excludes removal of effector cells
with Fc receptors . In order to avoid breakdown of cell-bound C3b to C3d by C3b
NRS a-E, NRS a-E,
1 ND E~ 50 :1 5 ND 6 80
2 ND Ec 25 :1 4 ND 4 80
3 ND Ec 5 :1 8 55 6 59
4 15 Eg 100 :1 8 35 10 ND
5 12 Eg 50 :1 4 34 3 ND
6 12 Eg 10 :1 5 33 3 39
Lymphocytes ER CRL*
NRS
E,
a-E,
E,C4(hu)
NRS
E,C4"y23
NRS
(hu)
a-E,
Untreated 54 15 0 35 0 0 42
FCS column passaged§ 57 23 0 26 1 1 44
HGG/anti-HGG column 77 4 0 1 1 0 11
passaged§P . PERLMANN, H . PERLMANN, AND H . J . MULLER-EBERHARD
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INA (24), HSA was used as the only protein supplement in the medium . These
experiments therefore suggest that antibody-dependent effector cells have
receptors for human C3b . Under the conditions used, no reaction with E,,C4 was
seen in rosette experiments . Lack of expression of bound C4b activity in these
experiments is due to the relatively small number of C4 molecules per cell
employed . C4b-dependent immune adherence (18) or rosette formation (27, 28)
requires 3,000-5,000 C4b molecules/cell .
The experiments in which cells with receptors for C(ra) were removed by
centrifugation ofE.AC(ra) rosettes confirmed the results of the column fractiona-
tion experiments with EHC4°"y23(hu) . Since the C6-deficient rabbit sera con-
tained C3b INA activity, both C3b and C3d are likely to be present on the
C-bearing Es . Preliminary experiments (unpublished results) suggest that
antibody-dependent cytolytic effector cells also have receptors for C3d, as has
been reported for CRL (29) .
Using similar centrifugation techniques for effector cell fractionation, van
Boxel et al . recently concluded that the antibody-dependent cytolytic effector
cells in mouse spleen belong to a subset of C receptor-bearing bone marrow-
derived lymphocytes (25) . Cell fractionation in the presence ofEDTA suggested
that these mouse effector cells had Mgt+ independentC receptors. Inhibition of
cytolysis by depletion ofEeAC(ra) rosette-forming cells in 0.005 MEDTA also
suggest that the cytolytic effector cells studied by us are distinct from mature
blood monocytes or polymorphonuclear neutrophiles (unpublished results) .
No lysis was obtained when the effector cells were incubated with target cells
bearing human C3b in the absence of IgG antibody . Incubation in the presence of
FCS, which converted most of the target cell-bound C3b to C3d, was as
ineffective in this respect as incubation in HSA which left C3b intact . In these
experiments the number of C3 molecules to target cells was 30,000, which was
more than three times the concentration needed for optimal rosette formation or
for depletion of effector cells on the C-charged columns, and more than three to
five times the concentration of IgG anti-E, needed for 50% lysis under similar
conditions in the absence of C (19) . However, while C alone did not induce a
cytolytic response of the effector cells, its presence on the target cells significantly
potentiated antibody-dependent lysis (Table IV) .
Experiments with erythrocytes bearing IgM antibody and C(ra) confirmed the
results obtained with C(hu) components . Target cell-bound C concentrations
sufficient for rosette formation were not at all capable to induce cell-mediated
lysis . That theC receptor on the effector cells has no direct role in the induction
of lysis was also apparent from experiments in which 0.2-40 Ag purified human
C3b' were added to incubation mixtures, containing lymphocytes, E,, and IgG
anti-E, (1 .5 x 106-3 x 108 molecules C3b/lymphocyte) . Under these conditions,
Cab neither inhibited nor enhanced the antibody-dependent cell-mediated
cytolysis (unpublished results) . These results are in line with those recently
reported by van Boxel et al . (7) . It thus seems that the interaction between the Fc
part of erythrocyte-bound IgG and the Fc receptor of the antibody-dependent
'Human C3b was a gift to Dr.V . Bokisch, Scripps Clinic and Research Foundation, La Jolla, Calif .
It was prepared by trypsinization of C3 and separated from C3a by Pevikon electrophoresis .294
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effector cells is of special importance to bring about the surface modulation
necessary for triggering the cytolytic events described in this paper . However, the
reaction between target cell-bound C and the C receptor of the effector cells
seems to amplify the attachment phase which is a prerequisite for antibody-
induced cell-mediated lysis . Although antibody-dependent cell-mediated lysis is
a nonphagocytic event (8) these results are reminiscent of earlier findings made
with mononuclear phagocytes of both human and mouse origin, suggesting that
the presence of activated C (C3) on IgM- or IgG-coated erythrocytes enhances
attachment to the phagocytes but that only IgG effectively induces ingestion (30,
31) .
Summary
Human blood lymphocytes were fractionated on glass bead columns charged with
sheep erythrocyte (E,,) membranes-bearing human C3b (7,000-10,000 molecules/
Eg ) . In the passaged cells the proportion of C receptor lymphocytes was strongly
reduced, in parallel with the capacity to lyse chicken erythrocytes (E,) in the
presence of IgG-rabbit anti-E, antibody . In other experiments, lymphocytes
forming rosettes with E S bearing activated rabbit complement [C(ra)] from
C6-deficient rabbits were removed by centrifugation through human serum
albumin-gelatine mixtures . This procedure also depleted the lymphocyte prepa-
rations of antibody-dependent cytolytic effector cells . The results suggest that
such effector cells have receptors for human C as well as for C(ra) .
Lymphocytes were not able to lyse erythrocytes bearing either human Cab
(^30,000 molecules/Ec ) or activated C(ra) in the absence if IgG antierythrocyte
antibodies . Under the same experimental conditions these target cells were
efficiently lysed in the presence of small amounts of IgG antitarget cell
antibodies . This suggests that the interaction between the cellular Fc-receptors
and the Fc part of the inducing antibodies is of special significance for the
triggering of the cell-mediated lytic reaction . However, although target cell-
bound C did not trigger cytolysis, it seemed to potentiate antibody-dependent
cytolysis, probably by enhancing effector cell-target cell contacts .
Received for publication 3 September 1974 .
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